Structure-specific amyloid precipitation in biofluids

Area of Science:

• Biochemistry
• Neuroscience
• Analytical Chemistry

Background:

• Toxic protein aggregates are implicated in neurodegenerative diseases.
• Their low concentration and heterogeneity in biofluids hinder in vivo analysis.
• Current methods lack the sensitivity and specificity for unbiased aggregate characterization.

Purpose of the Study:

• To develop a novel method for capturing and analyzing amyloid-containing protein aggregates from human biofluids.
• To enable unbiased determination of the molecular composition and structural features of in vivo aggregates.
• To advance the understanding of pathogenic mechanisms in neurodegenerative diseases.

Main Methods:

• Development of a structure-specific chemical dimer, CAP-1 (capture molecule for amyloid precipitation), targeting amyloid cross-β sheets.
• Immobilization of CAP-1 onto magnetic beads for efficient capture of amyloid aggregates.
• Isolation and characterization of captured aggregates using single-molecule fluorescence imaging and mass spectrometry.

Main Results:

• Amyloid precipitation successfully captures amyloid-containing aggregates from human cerebrospinal fluid.
• The method allows for unbiased isolation of these ultra-low concentration, heterogeneous aggregates.
• Characterization reveals molecular composition and structural features of in vivo aggregates.

Conclusions:

• Amyloid precipitation is a powerful, unbiased technique for studying toxic protein aggregates in neurodegenerative diseases.
• This method overcomes previous limitations in analyzing in vivo aggregate composition.
• It provides new insights into the molecular pathology of neurodegenerative conditions.